Publications by authors named "Heather A Walker"

Claim this Profile
E
Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva, Heather A Walker

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.
Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva, Heather A Walker

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL.
Inhye E Ahn, Danielle M Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A Walker

Blood Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia.
Christine E Ryan, Danielle M Brander, Paul M Barr, Svitlana Tyekucheva, Liam R Hackett, Heather A Walker

Leukemia· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing pictorial asthma action plans to promote self-management and health in rural youth with asthma: A qualitative study.
Christina L Duncan, Heather A Walker, Laurel Brabson, Desireé N Williford, Lisa Hynes

J Asthma· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perlecan-induced suppression of smooth muscle cell proliferation is mediated through increased activity of the tumor suppressor PTEN.
Pamela J Garl, Janet M Wenzlau, Heather A Walker, John M Whitelock, Mercedes Costell

Circ Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perlecan up-regulation of FRNK suppresses smooth muscle cell proliferation via inhibition of FAK signaling.
Heather A Walker, John M Whitelock, Pamela J Garl, Raphael A Nemenoff, Kurt R Stenmark

Mol Biol Cell· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis